Deriglidole

CAS No. 122830-14-2

Deriglidole( —— )

Catalog No. M32880 CAS No. 122830-14-2

Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 451 In Stock
5MG 604 In Stock
10MG 809 In Stock
25MG 1197 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Deriglidole
  • Note
    Research use only, not for human use.
  • Brief Description
    Deriglidole (SL 86-0715) is a peripheral adrenergic receptor antagonist that is a selective inhibitor of alpha2 receptors.
  • Description
    Deriglidole is a peripheral adrenoceptor antagonist with a high affinity for α2-adrenoceptors.
  • In Vitro
    Deriglidole is a selective α2-receptor inhibitor. Deriglidole inhibits [3H]Clonidine and [3H]Idazoxan but not [3H]Prazosin binding to rat cortical and human platelet α2-adrenoceptors and is more selective than Idazoxan for peripheral receptors.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    122830-14-2
  • Formula Weight
    255.36
  • Molecular Formula
    C16H21N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)C1(N2C=3C(C1)=CC=CC3CC2)C=4NCCN4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Natali A,et al. Effects of acute alpha 2-blockade on insulin action and secretion in humans. Am J Physiol. 1998 Jan;274(1 Pt 1):E57-64.?
molnova catalog
related products
  • Delequamine

    Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.

  • Tolamolol

    Tolamolol is a selective β-adrenergic blocker that significantly reduces the degree of exercise-induced inhibition of the S-T segment and can be used in the treatment of cardiac arrhythmias.

  • Butofilolol

    Butofilolol is a novel beta-blocker with antihypertensive activity and can be used to study hypertension.